Mike Polark
Stock Analyst at Wolfe Research
(2.88)
# 1,773
Out of 5,055 analysts
77
Total ratings
53.06%
Success rate
6.77%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $84.74 | - | 5 | Oct 29, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $180 → $220 | $167.51 | +31.34% | 9 | Oct 10, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $96.28 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $27.16 | -26.36% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $53.64 | +11.86% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $328.02 | +6.70% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $84.87 | +178.07% | 7 | May 6, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $25.10 | +15.54% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $244.71 | -26.44% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $88.64 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $360.13 | +12.46% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $546.71 | -8.00% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $130.03 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $103.86 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $58.49 | +106.87% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $18.34 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $15.26 | +63.83% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $147.03 | +12.22% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $101.76 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $12.95 | +0.39% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $4.76 | +341.18% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $257.01 | -2.73% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.54 | +2,692.21% | 1 | Sep 2, 2020 |
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $84.74
Upside: -
iRhythm Technologies
Oct 10, 2025
Maintains: Outperform
Price Target: $180 → $220
Current: $167.51
Upside: +31.34%
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $96.28
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $27.16
Upside: -26.36%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $53.64
Upside: +11.86%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $328.02
Upside: +6.70%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $84.87
Upside: +178.07%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $25.10
Upside: +15.54%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $244.71
Upside: -26.44%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $88.64
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $360.13
Upside: +12.46%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $546.71
Upside: -8.00%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $130.03
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $103.86
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $58.49
Upside: +106.87%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $18.34
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $15.26
Upside: +63.83%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $147.03
Upside: +12.22%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $101.76
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $12.95
Upside: +0.39%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $4.76
Upside: +341.18%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $257.01
Upside: -2.73%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.54
Upside: +2,692.21%